Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →38
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,214
Total Claims
$747K
Drug Cost
1,362
Beneficiaries
$548
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+341%
Opioid rate vs peers
89.0% vs 20.2% avg
+20%
Cost per patient vs peers
$548 vs $455 avg
+124%
Brand preference vs peers
7.0% vs 3.1% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid rate is 341% above Physical Medicine and Rehabilitation peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
89.0%
Opioid Rate
10,876
Opioid Claims
$655K
Opioid Cost
17.4%
Long-Acting Rate
This provider's opioid prescribing rate of 89.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 858 claims · $365K
Generic: 11,356 claims · $382K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 256 | $171K |
| Oxycodone Hcl/Acetaminophen | 3,499 | $139K |
| Hydrocodone/Acetaminophen | 2,820 | $88K |
| Oxycodone Hcl | 69 | $52K |
| Oxycodone Hcl | 1,693 | $35K |
| Tapentadol Hcl | 28 | $32K |
| Morphine Sulfate | 1,078 | $26K |
| Tapentadol Hcl | 33 | $26K |
| Fentanyl | 258 | $25K |
| Onabotulinumtoxina | 12 | $16K |
| Hydromorphone Hcl | 36 | $13K |
| Morphine Sulfate | 353 | $12K |
| Hydromorphone Hcl | 284 | $6,414 |
| Hydrocodone Bitartrate | 17 | $6,408 |
| Lidocaine | 35 | $5,764 |
Prescribing Profile
27
Unique Drugs
38.0
Anomaly Score
Patient Profile
67
Avg Age
63%
Female
2.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About